SCHEMBL4025836

SCHEMBL4025836

Cc1nc(Cc2cc(F)ccc2F)sc1C(N)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 1/20 0.43
GPR52 Q9Y2T5 6/20 0.43
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C19 P33261 2/20 0.42
LMNA P02545 1/20 0.42
SCD O00767 2/20 0.42
DPP4 P27487 2/20 0.41
HTR1A P08908 2/20 0.40
CDC7 O00311 1/20 0.40
CCNE1 P24864 1/20 0.40
CDK2 P24941 1/20 0.40
DBF4 Q9UBU7 1/20 0.40
MAPK8 P45983 1/20 0.39
DPP8 Q6V1X1 1/20 0.39
DPP9 Q86TI2 1/20 0.39
DPP7 Q9UHL4 1/20 0.39
RAB9A P51151 1/20 0.39
IKBKB O14920 1/20 0.38
GSK3B P49841 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27929449 0.81 SCD (0.53) GPR52CYP1A2CYP3A4CYP2C19LMNA
SCHEMBL4030637 0.81 GPR52 (0.47) CHRM4GPR52CYP1A2CYP3A4CYP2C19
SCHEMBL4032013 0.72 KLKB1 (0.56) GPR52CYP1A2CYP3A4CYP2C19LMNA
SCHEMBL347832 0.72 SCD (0.74) SCDHTR1A
SCHEMBL26011296 0.69 LMNA (0.42) CYP1A2CYP3A4CYP2C19LMNASCD
SCHEMBL18542001 0.69 RAB9A (0.43) CHRM4CYP1A2CYP2C19RAB9A
SCHEMBL18320904 0.69 SMN1; SMN2 (0.55) RAB9A
SCHEMBL14108643 0.68 SMN1; SMN2 (0.51) CHRM4SCDRAB9A
SCHEMBL3717542 0.67 CYP1A2 (0.61) CYP1A2CYP3A4CYP2C19LMNACDC7
SCHEMBL18542004 0.67 TSHR (0.56) CYP1A2CYP2C19RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054408-A2 HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RELATED TO ELEVATED LIPID LEVEL Novartis Ag (CH) 2009-05-06 EP disclosed
WO-2008127349-A2 HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RELATED TO ELEVATED LIPID LEVEL NOVARTIS AG (CH) 2008-10-23 WO disclosed